Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.4.1.2 (
acetyl-CoA carboxylase
)
2,876
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
FK520
(ascomycin), a 23-membered macrolide with immunosuppressive activity, is produced by Streptomyces hygroscopicus. The problem of low yield and high impurities (mainly FK523) limits the industrialized production of
FK520
. In this study, the
FK520
yield was significantly improved by strain mutagenesis and genetic engineering. First, a
FK520
high-producing strain SFK-6-33 (2432.2 mg/L) was obtained from SFK-36 (1588.4 mg/L) through ultraviolet radiation mutation coupled with streptomycin resistance screening. The endogenous crotonyl-CoA carboxylase/reductase (FkbS) was found to play an important role in
FK520
biosynthesis, identified with CRISPR/dCas9 inhibition system. FkbS was overexpressed in SFK-6-33 to obtain the engineered strain SFK-OfkbS, which produced 2817.0 mg/L of
FK520
resulting from an increase in intracellular ethylmalonyl-CoA levels. In addition, the
FK520
levels could be further increased with supplementation of crotonic acid in SFK-OfkbS. Overexpression of
acetyl-CoA carboxylase
(ACCase), used for the synthesis of malonyl-CoA, was also investigated in SFK-6-33, which improved the
FK520
yield to 3320.1 mg/L but showed no significant inhibition in FK523 production. To further enhance
FK520
production, FkbS and ACCase combinatorial overexpression strain SFK-OASN was constructed; the
FK520
production increased by 44.4% to 3511.4 mg/L, and the FK523/
FK520
ratio was reduced from 9.6 to 5.6% compared with that in SFK-6-33. Finally, a fed-batch culture was carried out in a 5-L fermenter, and the
FK520
yield reached 3913.9 mg/L at 168 h by feeding glycerol, representing the highest
FK520
yield reported thus far. These results demonstrated that traditional mutagenesis combined with metabolic engineering was an effective strategy to improve
FK520
production.
...
PMID:Enhancement of FK520 production in Streptomyces hygroscopicus by combining traditional mutagenesis with metabolic engineering. 3171 69